Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04237389
Other study ID # NRCSRussia02
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 22, 2019
Est. completion date August 31, 2022

Study information

Verified date January 2020
Source National Research Center of Surgery, Russia
Contact Irina A Taymasova
Phone +7(916)6028095
Email irina-tame@yandex.ru
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite good progress in the management of patients with atrial fibrillation (AF), this arrhythmia remains one of the major causes of stroke, heart failure, sudden death, and cardiovascular morbidity in the world. Furthermore, the number of patients with AF is predicted to rise steply in the coming years.

Even if the amount of antiarrhythmic drugs (AAD) is constantly increasing, there is a group of patients who has AF, resistant to AAD therapy. In such cases they are being offered alternative minimally invasive procedures, such as catheter or thoracoscopic ablation. With the discovery that AF often is initiated and maintained by electrical instability inside and around the pulmonary veins (PV) catheter and thoracoscopic ablation are now widely accepted invasive strategies to cure AF.

Even though the results of both of the procedures are very promising in treating patients with paroxysmal AF, the decision making process, which approach should be used in patients with persistant or LSPAF, is still very controversial.

According to 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, catheter or surgical ablation should be considered in patients with symptomatic persistent or long-standing persistent (LSP) AF refractory to AAD therapy to improve symptoms, considering patient choice, benefit and risk, supported by an AF Heart Team (IIaC).

Since, there is no actual evidence base, which approach is more effective and save in patients with persistant and LSP AF, the aim of the investigator's study is to evaluate the results of both of the approaches in such group of patients.


Description:

The aim of this study is to compare 2 approaches for AF treatment, endocardial catheter isolation of the pulmonary veins (PV) versus minimally invasive thoracoscopic surgical epicardial ablation.

The patients in both groups will be comparable and have persistant or LSP AF only. Patients with previous catheter ablations or any interventions or open heart procedures in the anamnesis will be excluded. The catheter ablation will be Ablation Index-guided, which means that every ablation point will be taken according to ablation quality marker which corporates power, delivery time, contact force (CF), and catheter stability, called Ablation Index (AI). Both of the procedures will be performed by a single identical protocol including wide complete circumferential ablation around the right and left PVs, and additional lines between the lower and upper PVs. The thoracoscopic procedure will be supplemented with removal of left atrial appendage (LAA).

In cases of AF or other atrial tachycardia recurrence after both procedures, every patient will undergo the opposite procedure (for example, if patient after thoracoscopic ablation will be diagnosed an AF recurrence, he will undergo catheter ablation). That is why there will be the third group, the so-called Hybrid procedure group of patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date August 31, 2022
Est. primary completion date August 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient is older than 18 years old

- Patient has nonparoxismal atrial fibrillation

- Sympthomatic AF

- Patient is refractory to at least one antiarrhythmic drug

- Indications for catheter or thoracoscopic ablation

- Absence of previous failed catheter or surgical AF ablations

- Patients agreement

Exclusion Criteria:

- Patient is younger than 18 years old

- Contraindications for catheter or thoracoscopic ablation

- Any previous heart surgeries (open/interventional)

- Congenital heart diseases

- Paroxismal AF

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Ablation Index Guided endocardial catheter radiofrequency ablation
Ablation Index (AI) guided catheter RF ablation with circumferential ablation around the right and left PVs and 2 additional lines between the lower and upper PVs (endoBox-lesion).
minimally invasive thoracoscopic surgical epicardial ablation.
Description: minimally invasive thoracoscopic surgical epicardial ablation using "Box-lesion" set, which includes isolation of the right and left PVs, roof and posterior wall lines and removal of the LAA.

Locations

Country Name City State
Russian Federation A.V. Vishnevsky National Medical Research Center of Surgery Moscow

Sponsors (1)

Lead Sponsor Collaborator
National Research Center of Surgery, Russia

Country where clinical trial is conducted

Russian Federation, 

References & Publications (1)

Castellá M, Kotecha D, van Laar C, Wintgens L, Castillo Y, Kelder J, Aragon D, Nuñez M, Sandoval E, Casellas A, Mont L, van Boven WJ, Boersma LVA, van Putte BP. Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST r — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Freedom from AF and other atrial tachycardia Freedom from AF and other atrial tachycardias, lasting more than 60 sec, determined by 24-hour Holter monitoring.
Other atrial tachycardias include left atrial flutters, typical atrial flutters
12 month
Primary Major adverse cardiac and cerebral events (MACCE) MACCE include death, stroke, transitory ischemic attack, hemopericarditis, implantation if pacemaker. 12 month
Secondary Freedom of AAD Freedom from any AAD and anticoagulation 12 month
Secondary Postoperative hospitalization duration The ammount of days after the procedure, wich were spent in the hospital 2 month
Secondary Decrease in the frequency of AF episodes Decrease of the ammount of AF episodes 12 month
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04544397 - Outcomes of Second Generation Laser Balloon Ablation for Atrial Fibrillation
Completed NCT04473963 - FLOW-AF: A Study to Evaluate the Ablacon Electrographic FLOW EGF Technology N/A
Recruiting NCT04715425 - Thoracoscopic Surgical Versus Catheter Ablation Approaches for Primary Treatment of Persistent Atrial Fibrillation N/A
Completed NCT04045067 - Low-voltage Areas Defragmentation in Sinus Rhythm for Radiofrequency Ablation of Persistent Atrial Fibrillation
Enrolling by invitation NCT04148625 - Subxyphoid Hybrid MAZE Registry for Patients With Persistent Atrial Fibrillation
Active, not recruiting NCT05481359 - AF-FLOW Registry: This Study is to Evaluate Ablamap Software in Patients Undergoing Ablation for Atrial Fibrillation.
Completed NCT06260670 - FLOW EVAL-AF: FLOW Mapping Electrogram VALidation in Patients With Persistent Atrial Fibrillation N/A
Recruiting NCT05883631 - RESOLVE-AF: Clinical Evaluation of the Ablacathâ„¢ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy. N/A
Recruiting NCT04942834 - Using Cryoballoon Ablation as Initial Treatment for Persistent Atrial Fibrillation N/A
Recruiting NCT04606693 - Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates N/A
Enrolling by invitation NCT04508491 - Cognitive Function in Patients With Persisted Atrial Fibrillation N/A
Active, not recruiting NCT05507749 - Cyroablation for Pulmonary Vein Isolation Alone in Patients With Early Persistent AF Assessed by Continuous Monitoring N/A
Not yet recruiting NCT06098989 - A Prospective Study of REPeat Ablation In Patients With Recurrent PERSistent Atrial Fibrillation: Pulmonary Vein Isolation vs. Adjunct Posterior Wall Isolation (REPAIR PERS-AF Study) N/A
Recruiting NCT05575557 - Pulmonary Artery Pressure and Right Heart Evaluation for Patients Requiring Physiological Pacing Treatment N/A
Recruiting NCT05411614 - Hybrid AbLaTion of Atrial Fibrillation N/A
Recruiting NCT04342312 - Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
Recruiting NCT04542785 - Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation. The Danish Atrial Fibrillation Randomised Clinical Trial N/A
Terminated NCT04206917 - MultiPulse Therapy (MPT) for AF N/A
Recruiting NCT04229160 - Noninvasive 3D Mapping in Persistent Atrial Fibrillation, to Describe Modifications of the Arrhythmogenic Substrate After Pulmonary Vein Isolation and Identify Potential Predicting Factors of Ablation Success N/A
Not yet recruiting NCT05883722 - Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation N/A